These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 23246221)
1. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes. Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221 [TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome. Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200 [TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of let-7a-3 is associated with poor prognosis in myelodysplastic syndrome. Wu DH; Yao DM; Yang L; Ma JC; Wen XM; Yang J; Guo H; Li XX; Qian W; Lin J; Qian J Leuk Lymphoma; 2017 Jan; 58(1):96-103. PubMed ID: 27244225 [TBL] [Abstract][Full Text] [Related]
4. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome. Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273 [TBL] [Abstract][Full Text] [Related]
5. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia. Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes. Choi JS; Nam MH; Yoon SY; Kang SH Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751 [TBL] [Abstract][Full Text] [Related]
7. Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes. Wan C; Wen J; Liang X; Xie Q; Wu W; Wu M; Liu Z Sci Rep; 2021 Jan; 11(1):183. PubMed ID: 33420276 [TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes. Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714 [TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Zuo Z; Calin GA; de Paula HM; Medeiros LJ; Fernandez MH; Shimizu M; Garcia-Manero G; Bueso-Ramos CE Blood; 2011 Jul; 118(2):413-5. PubMed ID: 21602527 [TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes. Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation. Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest. Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917 [TBL] [Abstract][Full Text] [Related]
13. [Expression and Function of miR-99a-5p in Bone Marrow of Patients with MDS]. LE Y; Zhang XP; Xiong YQ; Li HY; Zhao WH; Long Y; Luo J; Cheng P; Liu ZF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):134-140. PubMed ID: 30738460 [TBL] [Abstract][Full Text] [Related]
14. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Hofmann WK; de Vos S; Komor M; Hoelzer D; Wachsman W; Koeffler HP Blood; 2002 Nov; 100(10):3553-60. PubMed ID: 12411319 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression. Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838 [TBL] [Abstract][Full Text] [Related]
17. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes]. Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866 [TBL] [Abstract][Full Text] [Related]
18. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O Leuk Res; 2010 Mar; 34(3):328-34. PubMed ID: 19615744 [TBL] [Abstract][Full Text] [Related]
19. The effect of miR-223 on cellular behaviour in non-5q myelodysplastic syndromes through targeting RPS14. Nie Y; Wang S; Yu Y; Zuo X; Xiong B Pathology; 2020 Aug; 52(5):552-560. PubMed ID: 32571542 [TBL] [Abstract][Full Text] [Related]
20. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes. Li X; Marcondes AM; Gooley TA; Deeg HJ Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]